COMMUNIQUÉS West-GlobeNewswire

CareDx Adds HistoMap To Testing Portfolio
24/09/2019
CareDx partners with NanoString to improve precision of transplant biopsies BRISBANE, Calif., Sept. 24, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery [...]
Spectral Medical Launches the Tigris Trial
24/09/2019
TORONTO, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ( “Spectral” or the “Company” ) (TSX: EDT) , a Phase III company developing the first treatment for patients with septic shock guided by a companion [...]
REPEAT - AgraFlora Organics Provides Operational Update and Sales License Guidance at AAA Heidelberg Craft Cannabis Facility
24/09/2019
VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF ), a growth oriented and diversified [...]
Avadel Pharmaceuticals Announces Pharmacokinetic (PK) Data for Once-Nightly FT218 that will be Included in an Oral Presentation at the World Sleep 2019 Congress on September 25th
24/09/2019
DUBLIN, Ireland, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, for narcolepsy, today [...]
Auxly Announces Closing of Previously Announced $84 Million Credit Facilities Through its Joint Venture Partner, Sunens Farms Inc.
24/09/2019
VANCOUVER, British Columbia, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that its joint venture partner, Sunens Farms Inc. (“ Sunens [...]
Capricor Therapeutics to Meet with FDA to Discuss CAP-1002 to Treat Duchenne Muscular Dystrophy
24/09/2019
Company Exploring Potential for Accelerated Approval under RMAT Designation, an Expedited Program for Regenerative Therapies LOS ANGELES, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a [...]
Medtronic Surgical Synergy(SM) is Advanced with Range of New Procedural Solutions Unveiled at NASS 2019
24/09/2019
michelson_logo Delivers the Industry’s Most Complete Portfolio of Implants, Biologics, Imaging, Navigation, Robotics, and Surface Technologies Designed to Transform Spine Outcomes Marks Milestone Surpassing 1,000 Mazor [...]
RTI Surgical® Announces Commercial Launch of the CervAlign® Anterior Cervical Plate System
24/09/2019
RTI expands its Established Therapies spine portfolio to further meet surgeon and patient needs DEERFIELD, Ill., Sept. 24, 2019 (GLOBE NEWSWIRE) -- RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical implant [...]
Summit Therapeutics to Present Data from Phase 2 Clinical Trial of Ridinilazole at ID Week 2019
24/09/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics to Present Data from Phase 2 Clinical Trial of Ridinilazole at ID Week 2019 Oxford, UK, and Cambridge, MA, US, 24 September 2019 – Summit [...]
T2 Biosystems’ T2Resistance™ Panel is First Diagnostic to Graduate from CARB-X Portfolio
24/09/2019
Graduation underscores the critical progress that T2MR® technology has made in the rapid diagnosis of bacterial infections and accelerating time to appropriate treatment LEXINGTON, Mass., Sept. 24, 2019 (GLOBE NEWSWIRE [...]
Kamada to Present Corporate Overview at the 2019 Cantor Global Healthcare Conference
24/09/2019
REHOVOT, Israel, Sept. 24, 2019 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ and TASE: KMDA), a plasma-derived protein therapeutics company, announced today that Amir London, Chief Executive Officer, will provide a corporate [...]
Ivy Brain Tumor Center and BridgeBio Subsidiary QED Therapeutics Announce Collaboration to Advance Cancer Research and Treatment Options
24/09/2019
Preclinical study designed to test investigational agent infigratinib for the treatment of glioblastoma PHOENIX, Sept. 24, 2019 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, today [...]
Constellation Pharmaceuticals Advances CPI-0209 into Clinical Trials, Expanding its EZH2 Franchise
24/09/2019
Potential best-in-class EZH2 inhibitor focused on targeted patient segments was identified using Constellation’s epigenetics platform CAMBRIDGE, Mass., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , [...]
Aleafia Health Provides Guidance for Profitable Third Quarter 2019
24/09/2019
Company maintains strong balance sheet with $51 million in cash on hand Construction of Paris Phase II Processing facility expected to be completed in October 2019 Active, registered patients increased to over 10,000, a [...]
MediPharm Labs Enters European Medical Cannabis Market with German Pharmaceutical and Medical Cannabis Distributor ADREXpharma®
24/09/2019
First extraction-only company with supply agreement for export to Germany Second international distribution milestone further expands the Company’s global supply chain Demonstrates increasing international export [...]
Rexahn to Explore Strategic Alternatives
24/09/2019
ROCKVILLE, Md., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NasdaqCM: REXN) today announced that it has commenced a process to explore and evaluate strategic alternatives to enhance shareholder [...]
European Commission Grants Orphan Drug Designation for Nirogacestat for the Treatment of Soft Tissue Sarcoma
24/09/2019
STAMFORD, Conn., Sept. 24, 2019 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare [...]
Fennec Appoints Jodi A. Cook, PhD to Its Board of Directors
24/09/2019
RESEARCH TRIANGLE PARK, N.C., Sept. 24, 2019 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK TM (a unique formulation of [...]
BioAdaptives, Inc. Announces TizHemp, a New Hemp-Product Division, & Appointment of New CFO
24/09/2019
Las Vegas, Nevada, Sept. 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioAdaptives, Inc. (OTC BB: BDPT) announced the Company’s formation of TizHemp, a new operating division to concentrate efforts on wellness- [...]

Pages